Article Versions Notes

Shen H, Lundy J, Strickland AH, Harris M, Swan M, Desmond C, Jenkins BJ, Croagh D. KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation? Cells. 2022; 11(19):3175. https://doi.org/10.3390/cells11193175

Shen, Henry, Joanne Lundy, Andrew H. Strickland, Marion Harris, Michael Swan, Christopher Desmond, Brendan J. Jenkins, and Daniel Croagh. 2022. "KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?" Cells 11, no. 19: 3175. https://doi.org/10.3390/cells11193175

Shen, H., Lundy, J., Strickland, A. H., Harris, M., Swan, M., Desmond, C., Jenkins, B. J., & Croagh, D. (2022). KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation? Cells, 11(19), 3175. https://doi.org/10.3390/cells11193175